|
| 37517601 | Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study. | Int J Radiat Oncol Biol Phys | 2024 |
| 37980689 | Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis? | Int Urol Nephrol | 2024 |
| 38055287 | Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls. | Cancer | 2024 |
| 36594579 | Longitudinal associations of adherence to lifestyle recommendations and health-related quality of life in patients with non-muscle invasive bladder cancer. | | 2023 |
| 36372132 | Sociodemographic, lifestyle and clinical characteristics of energy-related depression symptoms: A pooled analysis of 13,965 depressed cases in 8 Dutch cohorts. | J Affect Disord | 2023 |
| 38020478 | Genetic relationship between the immune system and autism. | Brain Behav Immun Health | 2023 |
| 37822514 | Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial. | Eur Urol Open Sci | 2023 |
| 37996278 | Health-related Quality of Life During the First 4 Years After Non-Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort. | | 2023 |
| 37800635 | Body mass index and waist circumference in relation to risk of recurrence and progression after non-muscle invasive bladder cancer. | | 2023 |
| 37696273 | The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis. | Lancet Diabetes Endocrinol | 2023 |
| 37289470 | Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers: A Systematic Review. | | 2023 |
| 36972960 | Cohort profile - the Renal cell cancer: Lifestyle, prognosis and quality of life (ReLife) study in the Netherlands. | | 2023 |
| 36841687 | Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]. | Eur Urol | 2023 |
| 37471639 | Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk. | Hum Mol Genet | 2023 |
| 37410486 | Association of Risk Variants in the CFH Gene With Elevated Levels of Coagulation and Complement Factors in Idiopathic Multifocal Choroiditis. | JAMA Ophthalmol | 2023 |
| 37150255 | Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. | J Thorac Oncol | 2023 |
| 37210288 | Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. | Eur Urol | 2023 |
| 37205426 | Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. | medRxiv | 2023 |
| 37198015 | Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. | Eur Urol | 2023 |
| 37195314 | The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients. | | 2023 |
| 37124522 | A comparison of machine learning models for predicting urinary incontinence in men with localized prostate cancer. | Front Oncol | 2023 |
| 36867616 | Development and external validation of multivariate prediction models for erectile dysfunction in men with localized prostate cancer. | PLoS One | 2023 |
| 36693678 | Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections. | | 2023 |
| 37246479 | Staging fluorodeoxyglucose positron emission tomography/computed tomography for muscle-invasive bladder cancer: a nationwide population-based study. | | 2023 |
| 37187720 | Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies? | | 2023 |
| 37369443 | Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis. | Can J Surg | 2023 |
| 36931692 | Meta-analysis of erosive hand osteoarthritis identifies four common variants that associate with relatively large effect. | Ann Rheum Dis | 2023 |
| 36863459 | Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: A nationwide cohort study. | | 2023 |
| 36688720 | Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. | J Natl Cancer Inst | 2023 |
| 37236969 | Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. | Nat Commun | 2023 |
| 37047060 | Molecular Landscape of Pelvic Organ Prolapse Provides Insights into Disease Etiology. | | 2023 |
| 36670042 | Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum. | Eur Urol Oncol | 2023 |
| 36914746 | Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. | | 2023 |
| 34872047 | Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study. | Clinical Nutrition | 2022 |
| 35654644 | Corrigendum to "Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study". | Urol Oncol | 2022 |
| 36238604 | Genome-wide association study in patients with posterior urethral valves. | Front Pediatr | 2022 |
| 35700037 | Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35500836 | A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians. | J Thorac Oncol | 2022 |
| 36210504 | Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. | J Natl Cancer Inst | 2022 |
| 35740506 | Genome-Wide Meta-Analysis Identifies Variants in <i>DSCAM</i> and <i>PDLIM3</i> That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib. | Cancers (Basel) | 2022 |
| 35421819 | Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands. | Cancer Treat Res Commun | 2022 |
| 36202890 | Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma. | Scientific Reports | 2022 |
| 35915169 | Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. | Nat Genet | 2022 |
| 36581909 | Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study. | BMC Cancer | 2022 |
| 36632160 | The association of body composition with postoperative complications and length of hospital stay after radical or partial nephrectomy in patients with renal cell cancer: a multicenter population-based cohort study. | | 2022 |
| 34344231 | Potential role for immune-related genes in autism spectrum disorders: Evidence from genome-wide association meta-analysis of autistic traits. | Autism | 2022 |
| 34353775 | Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer. | Eur Urol Oncol | 2022 |
| 35039230 | Evidence or Prejudice? Critical Re-Analysis of Randomized Controlled Trials Comparing Overall Survival After Cisplatin Versus Carboplatin-Based Regimens in Advanced Urothelial Carcinoma. | Clin Genitourin Cancer | 2022 |
| 35205807 | The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care-A Systematic Review. | Cancers (Basel) | 2022 |
| 35205711 | Limited Changes in Lifestyle Behaviours after Non-Muscle Invasive Bladder Cancer Diagnosis. | Cancers | 2022 |